v3.26.1
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Stock Options Activity

The following table sets forth the activity of the options to purchase common stock under the 2019 Plan.

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

 
Outstanding as of December 31, 2024   93   $50,646.00 
Granted   9,050    44.80 
Exercised   -    - 
Expired   -   - 
Canceled   (20)   100,098.03 
Balance as of December 31, 2025   9,123    582.89 
Exercisable as of December 31, 2025   2,358   $578.91 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The fair value of each option granted is estimated as of the grant date using the Black-Scholes option pricing model with the following assumptions:

 

   Years ended December 31, 
   2025   2024 
Expected term (in years)   5.50    5.50 
Expected stock price volatility   150.67%   150%
Expected dividend yield   -%   -%
Risk-free interest rate range   3.80%   3.95%
Schedule of Share Based Payments Arrangements Options Exercised and Options Vested

 

  

Total Intrinsic

Value of Options

Exercised

  

Total Fair

Value of Options

Vested

 
Year ended December 31, 2024  $-   $278,406 
Year ended December 31, 2025  $-   $40,090